Two Sigma Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-15,000
Closed -$7.8M 2104
2024
Q3
$7.8M Buy
15,000
+10,200
+213% +$5.45M 0.13% 190
2024
Q2
$2.6M Sell
4,800
-3,300
-41% -$1.74M 0.03% 597
2024
Q1
$4.2M Sell
8,100
-10,600
-57% -$5.27M 0.04% 458
2023
Q4
$8.82M Buy
18,700
+16,000
+593% +$7.4M 0.09% 227
2023
Q3
$1.18M Sell
2,700
-3,200
-54% -$1.45M 0.01% 937
2023
Q2
$2.62M Buy
5,900
+1,500
+34% +$692K 0.04% 495
2023
Q1
$2.02M Buy
4,400
+2,000
+83% +$952K 0.04% 520
2022
Q4
$1.23M Buy
2,400
+400
+20% +$203K 0.04% 600
2022
Q3
$908K Buy
+2,000
New +$957K 0.03% 692
2022
Q2
Sell
-1,000
Closed -$491K 2380
2022
Q1
$491K Buy
+1,000
New +$457K 0.02% 1029
2021
Q1
Sell
-4,300
Closed -$1.38M 1095
2020
Q4
$1.38M Buy
4,300
+100
+2% +$30.7K 0.03% 320
2020
Q3
$1.13M Buy
+4,200
New +$1.13M 0.02% 325
2020
Q2
Sell
-2,200
Closed -$499K 1448
2020
Q1
$499K Sell
2,200
-30,100
-93% -$8.2M 0.01% 630
2019
Q4
$9.76M Buy
32,300
+7,600
+31% +$2.09M 0.07% 237
2019
Q3
$5.93M Buy
24,700
+18,200
+280% +$4.99M 0.05% 278
2019
Q2
$1.83M Hold
6,500
0.02% 490
2019
Q1
$1.86M Buy
6,500
+4,400
+210% +$1.27M 0.02% 356
2018
Q4
$552K Sell
2,100
-31,000
-94% -$8.52M 0.01% 940
2018
Q3
$9.07M Buy
33,100
+9,500
+40% +$2.47M 0.06% 233
2018
Q2
$5.62M Sell
23,600
-18,400
-44% -$4.26M 0.03% 465
2018
Q1
$9.23M Buy
42,000
+38,900
+1,255% +$9.14M 0.05% 302
2017
Q4
$698K Buy
+3,100
New +$660K 0.02% 550

Other funds holding ELV

Two Sigma Securities's ELV Position: Q1 2026 in Review

Two Sigma Securities reduced its Elevance Health (ELV) stake by 23% in Q1 2026, selling an estimated $136K and leaving 1,367 shares worth $400K. The position accounts for 0.05% of the portfolio, ranked #581.

Two Sigma Securities first reported a position in ELV in Q3 2016 and has held it in 26 quarters since. The position peaked at $2.17M in Q3 2024. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Two Sigma Securities held 1,367 shares of Elevance Health worth $400K as of Q1 2026.
  • Two Sigma Securities sold 415 Elevance Health shares in Q1 2026, an estimated $136K.
  • Elevance Health made up 0.05% of Two Sigma Securities's portfolio in Q1 2026, its #581 holding.
  • Two Sigma Securities first reported a position in Elevance Health in Q3 2016 and has held it in 26 quarters since.
  • Two Sigma Securities's Elevance Health position peaked at $2.17M in Q3 2024.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.